Critical Care

official impact factor 4.60

Highly Access Review

Clinical review: Ketones and brain injury

Hayden White and Balasubramanian Venkatesh*

Critical Care 2011, 15:219 doi:10.1186/cc10020

Neurotoxicity of ketones

Heikki Savolainen   (2011-05-25 15:05)  Dept. of Occup.Safety & Hlth., Tampere, Finland email

Dear Editor,

The ideas raised in the review (1) are excellent. It is now clear that L-lactate, for example, has also important regulatory roles in addition to its fuel characteristics (2).

However, many diketones, e.g. methylglyoxal (3)and diketohexane (4), toxic. The former is a metabolite of glucose and the second is derived from n-hexane, an industrial solvent. The compounds can form so-called Schiff bases with the free amino groups in the polypeptides rendering them nonfunctional or directly harmful.

Lastly, the end metabolite of methylglyoxal is D-lactate which cannot be metabolized as well as the physiological L form. However, it is taken up by the same monocarboxylate transporters as L-lactate thus accumulating in the cells. While using the ketone treatment it might be necessary to control the excretion of D-lactate (3) to avoid the toxicity associated with it.

1 White H, Venkatesh B. Critical review. Ketones and brain injury. Crit Care 2011, 15: 219

2 Rinholm JE, Hamilton NB, Kessaris N, et al. Regulation of oligodendrocyte development and myelination by glucose and lactate. J Neurosci 2011, 31: 538.

3 Talasniemi JP, Pennanen S, Savolainen H, et al. Assay of D-lactate in diabetic plasma and urine. Clin Biochem 2008, 41: 1099.

4 Savolainen H. Neurotoxicity of industrial chemicals and contaminants. Aspects of biochemical mechanisms and effects. Arch Toxicol 1982, suppl 5: 71

Competing interests

None

top

Post a comment